A carregar...

Practical Approach to Use of Abiraterone in Castration Resistant Prostate Cancer

INTRODUCTION: While androgen deprivation therapy remains the primary treatment modality for patients with metastatic prostate cancer, treatment is uniformly marked by progression to castration-resistant prostate cancer (CRPC). Abiraterone is the first new drug to enter clinical practice in a series...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mostaghel, Elahe A., Lin, Daniel W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4139288/
https://ncbi.nlm.nih.gov/pubmed/24775725
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!